KYAN Therapeutics and Aesculape CRO Partner to Offer Drug Development Biopharma ServicesApril 1, 2022
Data on Novel HDACi Targeting KRAS-mutated Cancers presented at the AACR-KCA Joint Conference on Functional Precision Medicine in Solid TumorsNovember 11, 2021
Clinical Data on KYAN’s personalized oncology platform presented at the 2021 ASH Annual MeetingNovember 1, 2021
KYAN collaborates with IMCB to accelerate drug discovery and development of nucleic acid therapiesAugust 19, 2021
